Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

: GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis - JSON Representation

Raw json | Download

{
  "resourceType" : "EvidenceVariable",
  "id" : "179784",
  "meta" : {
    "versionId" : "3",
    "lastUpdated" : "2023-12-01T22:26:01.820Z",
    "profile" : [
      🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/group-assignment"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: EvidenceVariable 179784</b></p><a name=\"179784\"> </a><a name=\"hc179784\"> </a><a name=\"179784-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">version: 3; Last updated: 2023-12-01 22:26:01+0000</p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-group-assignment.html\">GroupAssignment</a></p></div><p><b>url</b>: <a href=\"https://fevir.net/resources/EvidenceVariable/179784\">https://fevir.net/resources/EvidenceVariable/179784</a></p><p><b>identifier</b>: FEvIR Object Identifier/179784</p><p><b>name</b>: Therapeutic_dose_anticoagulation_with_heparin_vs_Usual_care_pharmacologic_thromboprophylaxis</p><p><b>title</b>: GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis</p><p><b>status</b>: Active</p><p><b>publisher</b>: Computable Publishing LLC</p><p><b>contact</b>: <a href=\"mailto:support@computablepublishing.com\">support@computablepublishing.com</a></p><p><b>description</b>: </p><div><p>Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis in multi-platform RCT of anticoagulation for non-critically ill patients with COVID-19</p>\n</div><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication</a>: Evidence Communication</td><td><span title=\"Codes:\">group-assignment</span></td></tr></table><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>\n</div><p><b>author</b>: Brian S. Alper: </p><h3>RelatedArtifacts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Citation</b></td></tr><tr><td style=\"display: none\">*</td><td>Cite As</td><td><div><p>GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179784. Revised 2023-11-30. Available at: https://fevir.net/resources/EvidenceVariable/179784. Computable resource at: https://fevir.net/resources/EvidenceVariable/179784.</p>\n</div></td></tr></table><h3>Definitions</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 defined-in-handling-and-category}\">Defined in handling and category elements</span></td></tr></table><p><b>handling</b>: dichotomous variable</p><blockquote><p><b>category</b></p><p><b>name</b>: Therapeutic-dose anticoagulation with heparin</p><p><b>value</b>: <a href=\"Group-179786.html\">ExposureDefinition: Therapeutic-dose anticoagulation with heparin</a></p></blockquote><blockquote><p><b>category</b></p><p><b>name</b>: Usual-care pharmacologic thromboprophylaxis</p><p><b>value</b>: <a href=\"Group-179785.html\">ComparatorDefinition: Usual-care pharmacologic thromboprophylaxis</a></p></blockquote></div>"
  },
  "url" : "https://fevir.net/resources/EvidenceVariable/179784",
  "identifier" : [
    {
      "type" : {
        "coding" : [
          {
            "system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code" : "ACSN",
            "display" : "Accession ID"
          }
        ],
        "text" : "FEvIR Object Identifier"
      },
      "system" : "https://fevir.net",
      "value" : "179784",
      "assigner" : {
        "display" : "Computable Publishing LLC"
      }
    }
  ],
  "name" : "Therapeutic_dose_anticoagulation_with_heparin_vs_Usual_care_pharmacologic_thromboprophylaxis",
  "title" : "GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis",
  "status" : "active",
  "publisher" : "Computable Publishing LLC",
  "contact" : [
    {
      "telecom" : [
        {
          "system" : "email",
          "value" : "support@computablepublishing.com"
        }
      ]
    }
  ],
  "description" : "Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis in multi-platform RCT of anticoagulation for non-critically ill patients with COVID-19",
  "useContext" : [
    {
      "code" : {
        "system" : "https://fevir.net/resources/CodeSystem/179423",
        "code" : "evidence-communication",
        "display" : "Evidence Communication"
      },
      "valueCodeableConcept" : {
        "text" : "group-assignment"
      }
    }
  ],
  "copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
  "author" : [
    {
      "name" : "Brian S. Alper"
    }
  ],
  "relatedArtifact" : [
    {
      "type" : "cite-as",
      "citation" : "GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179784. Revised 2023-11-30. Available at: https://fevir.net/resources/EvidenceVariable/179784. Computable resource at: https://fevir.net/resources/EvidenceVariable/179784."
    }
  ],
  "definition" : {
    "concept" : {
      "coding" : [
        {
          "system" : "https://fevir.net/resources/CodeSystem/179423",
          "code" : "defined-in-handling-and-category",
          "display" : "Defined in handling and category elements"
        }
      ]
    }
  },
  "handling" : "dichotomous",
  "category" : [
    {
      "name" : "Therapeutic-dose anticoagulation with heparin",
      "valueReference" : {
        🔗 "reference" : "Group/179786",
        "type" : "Group",
        "display" : "ExposureDefinition: Therapeutic-dose anticoagulation with heparin"
      }
    },
    {
      "name" : "Usual-care pharmacologic thromboprophylaxis",
      "valueReference" : {
        🔗 "reference" : "Group/179785",
        "type" : "Group",
        "display" : "ComparatorDefinition: Usual-care pharmacologic thromboprophylaxis"
      }
    }
  ]
}